filings.toolsMedtronic 8-K 2025-11-18
Filed 2025-11-18. 1 sections, 8K characters. Original on sec.gov · Markdown · JSON
Form 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 18, 2025
Medtronic plc
(Exact name of Registrant as Specified in its Charter)
| Ireland | 1-36820 | 98-1183488 | ||||||||||||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
Building Two
Parkmore Business Park West
Galway, Ireland
(Address of principal executive offices) (Zip Code)
+353 1 438-1700
(Registrant’s telephone number, including area code)
| Not Applicable | ||
| Former name or former address, if changed since last report |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||
| Ordinary shares, par value $0.0001 per share | MDT | New York Stock Exchange | ||||||
| 1.125% Senior Notes due 2027 | MDT/27 | New York Stock Exchange | ||||||
| 0.375% Senior Notes due 2028 | MDT/28 | New York Stock Exchange | ||||||
| 3.000% Senior Notes due 2028 | MDT/28A | New York Stock Exchange | ||||||
| 3.650% Senior Notes due 2029 | MDT/29 | New York Stock Exchange | ||||||
| 2.950% Senior Notes due 2030 | MDT/30 | New York Stock Exchange | ||||||
| 1.625% Senior Notes due 2031 | MDT/31 | New York Stock Exchange | ||||||
| 1.000% Senior Notes due 2031 | MDT/31A | New York Stock Exchange | ||||||
| 3.125% Senior Notes due 2031 | MDT/31B | New York Stock Exchange | ||||||
| 0.750% Senior Notes due 2032 | MDT/32 | New York Stock Exchange | ||||||
| 3.375% Senior Notes due 2034 | MDT/34 | New York Stock Exchange | ||||||
| 3.875% Senior Notes due 2036 | MDT/36 | New York Stock Exchange | ||||||
| 2.250% Senior Notes due 2039 | MDT/39A | New York Stock Exchange | ||||||
| 1.500% Senior Notes due 2039 | MDT/39B | New York Stock Exchange | ||||||
| 1.375% Senior Notes due 2040 | MDT/40A | New York Stock Exchange | ||||||
| 4.150% Senior Notes due 2043 | MDT/43A | New York Stock Exchange | ||||||
| 4.200% Senior Notes due 2045 | MDT/45 | New York Stock Exchange | ||||||
| 1.750% Senior Notes due 2049 | MDT/49 | New York Stock Exchange | ||||||
| 1.625% Senior Notes due 2050 | MDT/50 | New York Stock Exchange | ||||||
| 4.150% Senior Notes due 2053 | MDT/53 | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 2.02. | Results of Operations and Financial Condition |
On November 18, 2025, Medtronic plc, a public limited company organized under the laws of Ireland, issued a press release announcing its second quarter fiscal year 2026 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report.
| Item 9.01. | Exhibits. |
(d) List of Exhibits
| Exhibit Number | Description | |||||||
| 99.1 | Press release of Medtronic plc, dated November 18, 2025 | |||||||
| 104 | Cover Page Interactive Data File (embedded with the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Medtronic plc | ||||||||||||||||||||
| By | /s/ Thierry Piéton | |||||||||||||||||||
| Date: November 18, 2025 | Thierry Piéton | |||||||||||||||||||
| Executive Vice President and Chief Financial Officer (Principal Financial Officer) |
EXHIBIT INDEX
| Exhibit Number | Description | |||||||
| 99.1 | Press release of Medtronic plc, dated November 18, 2025 | |||||||
| 104 | Cover Page Interactive Data File (embedded with the Inline XBRL document). |